Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Production and Sale of Blood Products	7.35B	8.18B	7.96B	6.57B	4.29B
Production and Sale of Blood Products Growth	-10.13%	2.67%	21.27%	53.16%	55.31%
Total	7.35B	8.18B	7.96B	6.57B	4.29B
Total Growth	-10.13%	2.67%	21.27%	53.16%	55.26%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
East China	2.60B	2.99B	2.98B	2.41B	1.54B
East China Growth	-13.09%	0.41%	23.53%	56.41%	54.31%
Southern China	1.55B	1.69B	1.86B	1.59B	1.03B
Southern China Growth	-8.53%	-8.96%	16.35%	54.14%	58.53%
Northern China	2.09B	2.10B	1.93B	1.54B	897.27M
Northern China Growth	-0.36%	8.90%	25.44%	71.45%	31.46%
Northeast China Region	264.70M	384.13M	298.30M	251.66M	172.13M
Northeast China Region Growth	-31.09%	28.77%	18.53%	46.20%	96.15%
Southwest Region	488.64M	484.42M	516.08M	323.00M	202.02M
Southwest Region Growth	0.87%	-6.13%	59.78%	59.89%	6.02%
Northwestern Region	304.93M	470.48M	363.76M	279.67M	167.32M
Northwestern Region Growth	-35.19%	29.34%	30.07%	67.14%	206.31%
Export	52.44M	56.69M	22.81M	169.23M	273.16M
Export Growth	-7.50%	148.56%	-86.52%	-38.05%	188.03%
Total	7.35B	8.18B	7.96B	6.57B	4.29B
Total Growth	-10.13%	2.67%	21.27%	53.16%	55.26%

Source: S&P Global Market Intelligence.